Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and outcomes of patients undergoing coronary computed tomography angiography for suspected acute coronary syndrome in the emergency department.

The international journal of cardiovascular imaging·2026
Same author

Investigating smiling asymmetries in Parkinson's disease through the whistle-smile reflex.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Analyzing the 'bradykinesia complex' in GBA1-associated Parkinson's disease: A series of three cases.

Clinical parkinsonism & related disorders·2026
Same author

Efficacy and safety of transcatheter left atrial appendage closure guided by transoesophageal echocardiography using standard and micro TEE probes: a single-center retrospective study.

Frontiers in cardiovascular medicine·2026
Same author

Pattern Changes and Recurrent Remissions in Cervical Dystonia: Insights from a Long-Term Treated Case.

Toxins·2026
Same author

Application of LLMs in CAD-RADS Classification and Patient Management.

Echocardiography (Mount Kisco, N.Y.)·2026

Related Experiment Video

Updated: May 9, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Cardiogenic shock is not a single entity: therapeutic implications.

Marco Marini1, Francesca Coraducci1, Matilda Shkoza1

  • 1Cardiology and Intensive Cardiac Care Unit (ICCU), Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71 60126 Torrette Ancona (AN), Italy.

European Heart Journal Supplements : Journal of the European Society of Cardiology
|May 8, 2026
PubMed
Summary

Cardiogenic shock (CS) requires early recognition and tailored treatments due to high mortality. Phenotyping patients using clinical, hemodynamic, and etiological factors improves risk assessment and personalized therapy for better outcomes.

Keywords:
Advanced treatmentCardiogenic shockPhenotype

Related Experiment Videos

Last Updated: May 9, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Translational Research

Background:

  • Cardiogenic shock (CS) is a critical condition with high mortality, despite advances in cardiovascular care.
  • Early recognition and tailored therapeutic strategies are crucial for improving patient outcomes.
  • The heterogeneity of CS necessitates advanced phenotyping approaches.

Purpose of the Study:

  • To explore the role of phenotyping in understanding and managing cardiogenic shock.
  • To highlight the importance of accurate risk stratification and personalized treatment strategies.
  • To review current approaches in CS management, including pharmacological and mechanical support.

Main Methods:

  • Clinical assessment including "cold and dry," "cold and congested," "warm and dry," and "warm and congested" presentations.
  • Aetiological classification encompassing ischemic, de novo heart failure, chronic heart failure decompensation, secondary, and mixed causes.
  • Application of advanced phenotyping strategies, including machine learning, and the Society for Cardiovascular Angiography and Interventions classification for severity stratification.

Main Results:

  • Mixed shock, combining pump failure and vasodilation, is linked to increased mortality and rapid deterioration.
  • Advanced phenotyping identifies distinct CS subgroups with unique prognostic and therapeutic needs.
  • The Society for Cardiovascular Angiography and Interventions classification offers a framework for severity assessment and monitoring.

Conclusions:

  • Accurate phenotyping is essential for dynamic risk assessment in cardiogenic shock.
  • Personalized therapeutic strategies, integrating medical management and mechanical support, are key to improving outcomes.
  • Optimizing cardiogenic shock care requires a multi-dimensional approach to patient assessment and treatment.